Follow the people · Insider
Jill Andersen
Jill Andersen files insider transactions with the SEC as a chief legal officer, secretary of Invivyd (IVVD). We hold 4 disclosed purchases and sales filed since 2 November 2021, 2 of them in the last 90 days.
- Files forIVVD
- Disclosed buys and sells4 in all, 2 in the last 90 days
- Last disclosure18 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 November 2022 — 18 August 2026Chief Legal Officer, Secretary · Invivyd (IVVD)24 Form 4 lines · source: SEC Form 4
- Filed 1 November 2021 — 30 January 2022Chief Legal Officer, Secretary · Adagio Therapeutics (ADGI)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
26 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 170,000 shares of InvivydSEC Form 418 August 2026Common Stock · traded 15 August 2026 · filed 18 August 2026
- ▼ sold on the open market 37,256 shares of InvivydSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 30,706 shares of InvivydSEC Form 418 August 2026Common Stock · traded 18 August 2026 · filed 18 August 2026
- exercised options over 170,000 shares of Invivyd (a derivative holding)SEC Form 418 August 2026Restricted Stock Units · traded 15 August 2026 · filed 18 August 2026
- exercised options over 165,000 shares of InvivydSEC Form 418 February 2026Common Stock · traded 15 February 2026 · filed 18 February 2026
- ▼ sold on the open market 32,771 shares of InvivydSEC Form 418 February 2026Common Stock · traded 17 February 2026 · filed 18 February 2026
- ▼ sold on the open market 34,939 shares of InvivydSEC Form 418 February 2026Common Stock · traded 18 February 2026 · filed 18 February 2026
- exercised options over 165,000 shares of Invivyd (a derivative holding)SEC Form 418 February 2026Restricted Stock Units · traded 15 February 2026 · filed 18 February 2026
- exercised options over 165,000 shares of Invivyd (a derivative holding)SEC Form 418 February 2026Restricted Stock Units · traded 15 February 2026 · filed 18 February 2026
- exercised options over 165,000 shares of InvivydSEC Form 418 February 2026Common Stock · traded 15 February 2026 · filed 18 February 2026
- ▼ sold on the open market 32,771 shares of InvivydSEC Form 418 February 2026Common Stock · traded 17 February 2026 · filed 18 February 2026
- ▼ sold on the open market 34,939 shares of InvivydSEC Form 418 February 2026Common Stock · traded 18 February 2026 · filed 18 February 2026
- was granted 820,000 shares of Invivyd (a derivative holding)SEC Form 430 January 2026Stock Option (Right to Buy) · traded 29 January 2026 · filed 30 January 2026
- was granted 820,000 shares of Invivyd (a derivative holding)SEC Form 430 January 2026Stock Option (Right to Buy) · traded 29 January 2026 · filed 30 January 2026
- exercised options over 165,000 shares of Invivyd (a derivative holding)SEC Form 419 August 2025Restricted Stock Units · traded 15 August 2025 · filed 19 August 2025
- exercised options over 165,000 shares of InvivydSEC Form 419 August 2025Common Stock · traded 15 August 2025 · filed 19 August 2025
- ▼ sold on the open market 33,352 shares of InvivydSEC Form 419 August 2025Common Stock · traded 18 August 2025 · filed 19 August 2025
- ▼ sold on the open market 49,402 shares of InvivydSEC Form 419 August 2025Common Stock · traded 19 August 2025 · filed 19 August 2025
- was granted 950,000 shares of Invivyd (a derivative holding)SEC Form 419 February 2025Stock Option (Right to Buy) · traded 15 February 2025 · filed 19 February 2025
- was granted 500,000 shares of Invivyd (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 15 February 2025 · filed 19 February 2025
- was granted 400,000 shares of Invivyd (a derivative holding)SEC Form 420 December 2023Stock Option (Right to Buy) · traded 18 December 2023 · filed 20 December 2023
- was granted 325,000 shares of Invivyd (a derivative holding)SEC Form 420 November 2023Stock Option (Right to Buy) · traded 17 November 2023 · filed 20 November 2023
- was granted 300,000 shares of Invivyd (a derivative holding)SEC Form 416 December 2022Stock Option (Right to Buy) · traded 14 December 2022 · filed 16 December 2022
- was granted 175,000 shares of Invivyd (a derivative holding)SEC Form 44 November 2022Stock Option (Right to Buy) · traded 3 November 2022 · filed 4 November 2022
- was granted 575,000 shares of Adagio Therapeutics (a derivative holding)SEC Form 41 February 2022Stock Option (Right to Buy) · traded 30 January 2022 · filed 1 February 2022
- was granted 514,863 shares of Adagio Therapeutics (a derivative holding)SEC Form 42 November 2021Stock Option (Right to Buy) · traded 1 November 2021 · filed 2 November 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.